Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors

Published:2014-01-30 Issue:1 Volume:1 Page:57-68
ISSN:2331-4737
Container-title:Oncoscience
language:en
Short-container-title:Oncoscience

Author:

Aggoune Djamel¹,Tosca Lucie²³⁴,Sorel Nathalie¹⁵,Bonnet Marie-Laure¹,Dkhissi Fatima¹,Tachdjian Gerard¹²³⁶,Bennaceur-Griscelli Annelise²³⁷,Chomel Jean-Claude¹⁵,Turhan Ali G.¹²³⁶

Affiliation:

1. INSERM, U935, F-86000 Poitiers, France

2. INSERM, U935, F-94800, Villejuif, France

3. Université Paris–Sud 11, F-94270 Le Kremlin-Bicêtre, France

4. Hôpital Antoine Béclère, Service d’Histologie-Embryologie-Cytogénétique, F-92140 Clamart, France

5. CHU de Poitiers, Service de Cancérologie Biologique, F-86000 Poitiers, France

6. Hôpital Bicêtre, Service d’Hématologie Biologique, F-94270 Le Kremlin Bicêtre, France

7. Hôpital Paul Brousse, Service d’Hématologie Biologique, F-94800 Villejuif, France

Publisher

Impact Journals, LLC

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia;Turkish Journal of Hematology;2023-05-30

2. Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs);Cancers;2023-05-03

3. miR-495-3p sensitizes BCR-ABL1-expressing leukemic cells to tyrosine kinase inhibitors by targeting multidrug resistance 1 gene in T315I mutated cells;Experimental Hematology;2023-02

4. miR-495-3p Sensitizes BCR::ABL1 Expressing Leukemic cells to Tyrosine Kinase Inhibitors by Targeting Multidrug Resistance 1 Gene including in T315I Mutated cells;2022-10-17

5. Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) using patient-derived induced pluripotent stem cells (iPSC);2022-09-12